AI Mood Market: Stock Dashboard

Company: Annovis Bio Inc

Sector: Healthcare

Industry: Biotechnology

Country: USA

Exchange: NYSE

Index: -

P/E: -

EPS (ttm): -1.48

Insider Own: 15.45%

Shs Outstand: 26.50M

Perf Week: -4.82%

Market Cap: 62.81M

Forward P/E: -

EPS next Y: -1.30

Insider Trans: 41.09%

Shs Float: 22.41M

Perf Month: -25.24%

Enterprise Value: 47.52M

PEG: -

EPS next Q: -0.31

Inst Own: 14.95%

Short Float: 13.10%

Perf Quarter: -2.47%

Income: -24.88M

P/S: -

EPS this Y: 43.52%

Inst Trans: 5.75%

Short Ratio: 1.79

Perf Half Y: -12.87%

Sales: 0.00M

P/B: 3.64

EPS next Y Percentage: 0.22%

ROA: -157.74%

Short Interest: 2.94M

Perf YTD: -31.50%

Book/sh: 0.65

P/C: 4.11

EPS next 5Y: 18.51%

ROE: -246.14%

52W High: 5.50 -56.91%

Perf Year: -8.85%

Cash/sh: 0.58

P/FCF: -

EPS past 3/5Y: -6.68% -73.95%

ROIC: -189.15%

52W Low: 1.11 113.51%

Perf 3Y: -88.05%

Dividend Est.: -

EV/EBITDA: -

Sales past 3/5Y: - -

Gross Margin: -

Volatility W: 8.13%

Volatility M: 7.96%

Perf 5Y: -89.07%

Dividend TTM: -

EV/Sales: -

EPS Y/Y TTM: 62.84%

Oper. Margin: -

ATR (14): 0.24

Perf 10Y: -

Dividend Ex-Date: -

Quick Ratio: 4.60

Sales Y/Y TTM: -

Profit Margin: -

RSI (14): 31.97

Recom: 1.00

Dividend Gr. 3/5Y: - -

Current Ratio: 4.60

EPS Q/Q: 62.13%

SMA20: -12.08%

Beta: 1.33

Target Price: 12.50

Payout: -

Debt/Eq: 0.00

Sales Q/Q: -

SMA50: -29.62%

Rel Volume: 0.13

Prev Close: 2.43

Employees: 8

LT Debt/Eq: 0.00

Earnings: Nov 12 BMO

SMA200: -11.71%

Avg Volume: 1.64M

Price: 2.37

IPO: Jan 29, 2020

Option/Short: Yes / Yes

EPS/Sales Surpr.: 1.78% -

Trades:

Volume: 216,558

Change: -2.47%

AI Market Mood: Stock Dashboard

ANVS

Fundamental

Technical:

Latest News:

Annovis Bio (NYSE: ANVS) to Present at H.C. Wainwright 26th Annual Global Investment Conference neutral

ANVS AVXL LGVN

Analysts Conflicted on These Healthcare Names: Annovis Bio (ANVS), Gilead Sciences ... somewhat bullish

ANVS GILD OMGA